CSG Pushes Into Washington With a Weapons Veteran, but the Stock Keeps Sliding on Empty Order Books
Veröffentlicht: 26.06.2026 um 15:17 Uhr, Redaktion boerse-global.de
The Czechoslovak Group (CSG) is executing its most ambitious strategic pivot in years, installing a seasoned defence dealmaker in Washington and rolling out new air defence hardware in Europe. The Prague-based company’s shares, however, are trading as if none of it matters. At €12.25 — or €12.32, depending on the day — the stock has shed roughly two-thirds of its value since January, when it debuted at €32 and briefly became one of Europe’s premier defence IPOs.
A pedigree built for the Pentagon
David Jacobs has been named president of CSG Defense North America, a newly created role that puts him in charge of a Washington D.C. office designed to court the US defence establishment. His résumé reads like a Pentagon wishlist: more than 15 years at Northrop Grumman and Raytheon, most recently as vice president for corporate strategy and M&A at Northrop Grumman, preceded by a decade in investment banking at Merrill Lynch where he closed over 60 transactions worth a combined $200bn.
His marching orders are precise — shape the North America strategy, lead acquisition efforts, and forge ties with decision-makers across industry and government. He will coordinate with CSG’s arms divisions in Prague and two existing US subsidiaries, MSM North America and CSE USA.
The numbers that should calm nerves
The operational picture looks nothing like the share price. In the first quarter of 2026, CSG generated €1.544bn in revenue, a 13.8% year-on-year jump. The order backlog swelled to €17bn, up 15.1%. Operating EBIT rose 8.7% to €372m, yielding a margin of 24.1%. Management confirmed the full-year guidance.
Should investors sell immediately? Or is it worth buying CSG?
On the ground, there is already a tentacle in the US defence supply chain: last year MSM Group North America won a US Army contract to build a 155mm artillery munitions factory at the Iowa Army Ammunition Plant. Meanwhile, at the Eurosatory exhibition, CSG unveiled its new Trident air defence system and sealed a strategic partnership with Ukrainian Armor LLC, extending its reach into a conflict zone where Western ammunition is in perpetual demand.
The market awards none of it
None of that has stopped the selling. The stock has lost more than 30% in the past 30 days alone, a drop so sharp that the relative strength index has fallen to 25 — territory that normally signals a bounce. Yet no rebound has materialised. With annualised volatility of around 59%, the share price is swinging wildly, and the 52-week low is close enough to €12 that traders are watching that level as a potential line in the sand.
Some analysts argue the valuation has become absurd — that a company with near-double-digit revenue growth, a €17bn backlog, and credible expansion plans into the world’s largest defence market is priced for distress. But the sell-off suggests investors want more than press releases and biographical bulletins. A new office in Washington and a veteran M&A banker are not the same as signed contracts.
CSG at a turning point? This analysis reveals what investors need to know now.
What comes next
The market’s patience will be tested again on 7 August 2026, when CSG reports half-year earnings. That will be the first chance to see whether the North American push has left any measurable footprint on the profit-and-loss statement — or whether the equity’s slide has further to run before the numbers catch up with the narrative.
Ad
CSG Stock: New Analysis - 26 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
